BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34964255)

  • 41. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
    Zhang LJ; Lu XL; He J; Li Y
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia.
    Hoffmeister LM; Orhan E; Walter C; Niktoreh N; Hanenberg H; von Neuhoff N; Reinhardt D; Schneider M
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638301
    [No Abstract]   [Full Text] [Related]  

  • 44. Mitotic recombinatory evolution in acute leukemia.
    Papenhausen P; Kelly CA; Zhang Z; Penton A
    Cancer Genet; 2023 Jun; 274-275():33-40. PubMed ID: 36966725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.
    Balgobind BV; Raimondi SC; Harbott J; Zimmermann M; Alonzo TA; Auvrignon A; Beverloo HB; Chang M; Creutzig U; Dworzak MN; Forestier E; Gibson B; Hasle H; Harrison CJ; Heerema NA; Kaspers GJ; Leszl A; Litvinko N; Nigro LL; Morimoto A; Perot C; Pieters R; Reinhardt D; Rubnitz JE; Smith FO; Stary J; Stasevich I; Strehl S; Taga T; Tomizawa D; Webb D; Zemanova Z; Zwaan CM; van den Heuvel-Eibrink MM
    Blood; 2009 Sep; 114(12):2489-96. PubMed ID: 19528532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two cases of acute myeloid leukemia with t(11;17) associated with varying morphology and immunophenotype: rearrangement of the MLL gene and a region proximal to the RARalpha gene.
    Kang LC; Smith SV; Kaiser-Rogers K; Rao K; Dunphy CH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):168-73. PubMed ID: 15899392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
    Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
    J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.
    Liu XX; Pan XA; Gao MG; Kong J; Jiang H; Chang YJ; Zhang XH; Wang Y; Liu KY; Chen Z; Zhao XS; Huang XJ
    Int J Lab Hematol; 2023 Apr; 45(2):195-203. PubMed ID: 36358022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetics and associated mutation profile in patients with acute monocytic leukemia.
    Xing S; Wang B; Gao Y; Li M; Wang T; Sun Y; Shen Y; Chao H
    Int J Lab Hematol; 2019 Aug; 41(4):485-492. PubMed ID: 31099482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia.
    Hyrenius-Wittsten A; Pilheden M; Sturesson H; Hansson J; Walsh MP; Song G; Kazi JU; Liu J; Ramakrishan R; Garcia-Ruiz C; Nance S; Gupta P; Zhang J; Rönnstrand L; Hultquist A; Downing JR; Lindkvist-Petersson K; Paulsson K; Järås M; Gruber TA; Ma J; Hagström-Andersson AK
    Nat Commun; 2018 May; 9(1):1770. PubMed ID: 29720585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent
    Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
    Blood Adv; 2018 Nov; 2(21):2879-2889. PubMed ID: 30381403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new variant of KMT2A(MLL)-FLNA fusion transcript in acute myeloid leukemia with ins(X;11)(q28;q23q23).
    Matveeva E; Kazakova A; Olshanskaya Y; Tsaur G; Shelikhova L; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A
    Cancer Genet; 2015 Apr; 208(4):148-51. PubMed ID: 25892123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult Acute Myeloid Leukemia with the KMT2A-Mixed Lineage Leukemia T10 Fusion: An Analysis of 10 Cases Showed Common Features and Frequent Mutations in the RAS Signaling Pathway.
    Cai X; Wang J; Lu J; Jia Z; Chen M; Liu J; Lu X; Chao H
    Acta Haematol; 2022; 145(2):144-151. PubMed ID: 34551411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
    Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Acute myeloid leukemia with t(11;22) (q23;q11.2): two cases report and literature review].
    Wang T; Gao W; Liu HX; Teng W; Ren J; Wang CF; Zhang Y; Cao W; Wang H; Tong CR
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1028-31. PubMed ID: 24369159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical Characteristics and Prognostic Influencing Factors of Adult AML Patients with MLL Rearrangement].
    Wang T; Zhao Y; Zhang QQ; Xu LR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):775-780. PubMed ID: 32552935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
    Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.